Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.35+0.10 (+1.21%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Bausch Health Companies gross margin
Gross margin is gross profit as a percentage of revenue.
Bausch Health Companies's gross margin for the twelve months ending Jun 30, 2018 was 71.4%. For fiscal 2017 it was 71.3%, against 73.4% the year before. The highest annual figure on record is 75.8% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 71.3% | −2.1 |
| FY2016 | Dec 31, 2016 | 73.4% | −2.4 |
| FY2015 | Dec 31, 2015 | 75.8% | +2.3 |
| FY2014 | Dec 31, 2014 | 73.5% | +5.5 |
| FY2013 | Dec 31, 2013 | 68.0% | −6.0 |
| FY2012 | Dec 31, 2012 | 74.0% | +2.2 |
| FY2011 | Dec 31, 2011 | 71.8% | +5.3 |
| FY2010 | Dec 31, 2010 | 66.5% | −8.6 |
| FY2009 | Dec 31, 2009 | 75.1% | +1.1 |
| FY2008 | Dec 31, 2008 | 74.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | 72.6% | +1.0 |
| Q1 FY2018 | Mar 31, 2018 | 71.9% | −0.4 |
| Q4 FY2017 | Dec 31, 2017 | 70.6% | −2.2 |
| Q3 FY2017 | Sep 30, 2017 | 70.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 71.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 72.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 72.7% | – |
See a number that looks wrong?